Elligint Health raises $7M in November 2026 SEC filing

- Raised in SEC filings
- $23.3M
- Filings
- 3
- Latest est. round
- Series A
- Incorporated
- 2024
- Industry
- Tech
- Based in
- NJ
Elligint Health, incorporated in 2024, began filing with the SEC in January 2025. Its initial filing reported a $3.2 million seed round with a first sale date of December 27, 2024.
The company filed again in June 2025, reporting a $13.1 million estimated Series A round, also with a first sale date of December 27, 2024. Its latest filing in November 2026 reported a $7 million estimated Series A round with a first sale date of May 15, 2026. These rounds are estimates.
The latest filing names Lenard Marcus, Gregg Michaelson, Enrico Picozza, Michael Ludwig, Adam Sabloff, Danielle Bellanger, Ashish Kapoor, and Steven Tolle as directors. Elligint Health is based in NJ and operates in the Other Technology industry. We do not track its open roles yet.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-05-15 | $7M | Series A |
| 2024-12-27 | $13.1M | Series A |
| 2024-12-27 | $3.2M | Seed |
Named in the latest filing
- Lenard Marcus
- Gregg Michaelson
- Enrico Picozza
- Michael Ludwig
- Adam Sabloff
- Danielle Bellanger
- Ashish Kapoor
- Steven Tolle
- Chris Caramanico
- Sumesh Poyil
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR